InterWell Health is further expanding its kidney care services with the addition of Acumen Physician Solutions, the company announced Tuesday.
InterWell will acquire Acumen, which provides electronic health record and patient management software for nephrologists. InterWell was formed from the three-way merger of Cricket Health, Fresenius Health Partners and the original InterWell.
Acumen was formerly a division of Fresenius Medical Care North America.
“The addition of Acumen accelerates our ability to provide the most comprehensive offering to kidney care providers to support their move to value-based care,” said Robert Sepucha, CEO of InterWell Health, in the announcement.
“This technology is a perfect complement to our existing tools that are identifying high risk patients to reduce hospitalizations, and connecting patients with leading education platforms, care teams, and peer mentors," Sepucha added. "We are committed to slowing the progression of disease, increasing transplant rates, accelerating adoption of home dialysis, and improving health equity.”
Acumen's Epic Connect platform has been deployed by more than 2,000 kidney care providers and was designed in partnership with Epic, one of the largest EHR companies in the country. The platform is designed to support value-based care and includes payer integration, a physician rounding tool, embedded analytics, population health management options and interoperability with other providers.
Most (65%) of InterWell's network has adopted with the Epic Connect platform, the companies said.
“We are thrilled to be joining the new InterWell Health as they work to transform kidney care by improving the lives of people living with CKD earlier in the disease progression and reducing costs to public and private payers,” said Sam Gopal, president of Acumen Physician Solutions, in the release. “Our technology for physician practices will integrate seamlessly into InterWell Health’s existing capabilities and goals, and we hope even more providers will have the opportunity to partner with Acumen as a result of this transaction.”
The InterWell-Acumen deal does not require regulatory review, according to the announcement.